Continuing five or more locoregional therapies before living donor salvage liver transplantation for hepatocellular carcinoma is related to poor recurrence-free survival | Synapse
January 1, 2018Open Access
Continuing five or more locoregional therapies before living donor salvage liver transplantation for hepatocellular carcinoma is related to poor recurrence-free survival
Key Points
Key points are not available for this paper at this time.
Abstract
Continuing five or more locoregional therapies for recurrent HCC after LR is related to poor recurrence-free survival after SLT.